Trial intelligence / Profile preview

Topical bevacizumab eye drops as adjunct in trabeculectomy

TCTR20171114002Phase 3Not yet recruiting

Sponsor
Khon Kaen University
Start
Nov 2017
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

A Phase 3 trial of bevacizumab in Glaucoma, sponsored by Khon Kaen University. Planned start Nov 2017; status: not yet recruiting.

02

Drugs

bevacizumab
03

Conditions

Glaucoma

Beyond the preview

Go deeper on TCTR20171114002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20171114002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call